FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315566139> ?p ?o ?g. }

• W4315566139 endingPage "151" @default.
• W4315566139 startingPage "151" @default.
• W4315566139 abstract "Systemic autoinflammatory diseases (SAIDs) are defined by recurrent febrile attacks associated with protean manifestations involving joints, the gastrointestinal tract, skin, and the central nervous system, combined with elevated inflammatory markers, and are caused by a dysregulation of the innate immune system. From a clinical standpoint, the most known SAIDs are familial Mediterranean fever (FMF); cryopyrin-associated periodic syndrome (CAPS); mevalonate kinase deficiency (MKD); and periodic fever, aphthosis, pharyngitis, and adenitis (PFAPA) syndrome. Current guidelines recommend the regular sequential administration of vaccines for all individuals with SAIDs. However, these patients have a much lower vaccination coverage rates in ‘real-world’ epidemiological studies than the general population. The main purpose of this review was to evaluate the scientific evidence available on both the efficacy and safety of vaccines in patients with SAIDs. From this analysis, neither serious adverse effects nor poorer antibody responses have been observed after vaccination in patients with SAIDs on treatment with biologic agents. More specifically, no new-onset immune-mediated complications have been observed following immunizations. Post-vaccination acute flares were significantly less frequent in FMF patients treated with colchicine alone than in those treated with both colchicine and canakinumab. Conversely, a decreased risk of SARS-CoV-2 infection has been proved for patients with FMF after vaccination with the mRNA-based BNT162b2 vaccine. Canakinumab did not appear to affect the ability to produce antibodies against non-live vaccines in patients with CAPS, especially if administered with a time lag from the vaccination. On the other hand, our analysis has shown that immunization against Streptococcus pneumoniae, specifically with the pneumococcal polysaccharide vaccine, was associated with a higher incidence of adverse reactions in CAPS patients. In addition, disease flares might be elicited by vaccinations in children with MKD, though no adverse events have been noted despite concurrent treatment with either anakinra or canakinumab. PFAPA patients seem to be less responsive to measles, mumps, and rubella-vaccine, but have shown higher antibody response than healthy controls following vaccination against hepatitis A. In consideration of the clinical frailty of both children and adults with SAIDs, all vaccinations remain ‘highly’ recommended in this category of patients despite the paucity of data available." @default.
• W4315566139 created "2023-01-11" @default.
• W4315566139 creator A5022513530 @default.
• W4315566139 creator A5031340334 @default.
• W4315566139 creator A5058658304 @default.
• W4315566139 creator A5072093447 @default.
• W4315566139 creator A5074615917 @default.
• W4315566139 creator A5083092931 @default.
• W4315566139 creator A5086604902 @default.
• W4315566139 creator A5087840806 @default.
• W4315566139 date "2023-01-10" @default.
• W4315566139 modified "2023-10-01" @default.
• W4315566139 title "Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases" @default.
• W4315566139 cites W179204766 @default.
• W4315566139 cites W1950464121 @default.
• W4315566139 cites W1977164682 @default.
• W4315566139 cites W1984821014 @default.
• W4315566139 cites W1997139024 @default.
• W4315566139 cites W2048791692 @default.
• W4315566139 cites W2083291559 @default.
• W4315566139 cites W2105693411 @default.
• W4315566139 cites W2111897512 @default.
• W4315566139 cites W2125374122 @default.
• W4315566139 cites W2125858194 @default.
• W4315566139 cites W2144592499 @default.
• W4315566139 cites W2146401589 @default.
• W4315566139 cites W2161555922 @default.
• W4315566139 cites W2164112907 @default.
• W4315566139 cites W2262791344 @default.
• W4315566139 cites W2290885159 @default.
• W4315566139 cites W2310667568 @default.
• W4315566139 cites W2543852332 @default.
• W4315566139 cites W2569807093 @default.
• W4315566139 cites W2607337489 @default.
• W4315566139 cites W2611877288 @default.
• W4315566139 cites W2769056669 @default.
• W4315566139 cites W2783152327 @default.
• W4315566139 cites W2792559039 @default.
• W4315566139 cites W2793503759 @default.
• W4315566139 cites W2899199192 @default.
• W4315566139 cites W2911457392 @default.
• W4315566139 cites W2913302274 @default.
• W4315566139 cites W2924419862 @default.
• W4315566139 cites W2936207066 @default.
• W4315566139 cites W2940118982 @default.
• W4315566139 cites W2963806533 @default.
• W4315566139 cites W2967124351 @default.
• W4315566139 cites W2972635716 @default.
• W4315566139 cites W2994912883 @default.
• W4315566139 cites W3003065717 @default.
• W4315566139 cites W3004242928 @default.
• W4315566139 cites W3041662110 @default.
• W4315566139 cites W3093367571 @default.
• W4315566139 cites W3113774549 @default.
• W4315566139 cites W3118753478 @default.
• W4315566139 cites W3126857517 @default.
• W4315566139 cites W3133861861 @default.
• W4315566139 cites W3161242035 @default.
• W4315566139 cites W3178010802 @default.
• W4315566139 cites W3205292490 @default.
• W4315566139 cites W3215973509 @default.
• W4315566139 cites W3216623344 @default.
• W4315566139 cites W4213336147 @default.
• W4315566139 cites W4214839230 @default.
• W4315566139 cites W4214887441 @default.
• W4315566139 cites W4220966941 @default.
• W4315566139 cites W4224442167 @default.
• W4315566139 cites W4225300129 @default.
• W4315566139 cites W4226022832 @default.
• W4315566139 cites W4226178606 @default.
• W4315566139 cites W4244288916 @default.
• W4315566139 cites W4280580177 @default.
• W4315566139 cites W4281659269 @default.
• W4315566139 cites W4281739156 @default.
• W4315566139 cites W4283068917 @default.
• W4315566139 cites W4283169187 @default.
• W4315566139 cites W4285208151 @default.
• W4315566139 cites W4285803619 @default.
• W4315566139 cites W4287458449 @default.
• W4315566139 cites W4292869910 @default.
• W4315566139 cites W4293662859 @default.
• W4315566139 cites W4309773943 @default.
• W4315566139 cites W4310699964 @default.
• W4315566139 cites W4312066698 @default.
• W4315566139 doi "https://doi.org/10.3390/vaccines11010151" @default.
• W4315566139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36679996" @default.
• W4315566139 hasPublicationYear "2023" @default.
• W4315566139 type Work @default.
• W4315566139 citedByCount "0" @default.
• W4315566139 crossrefType "journal-article" @default.
• W4315566139 hasAuthorship W4315566139A5022513530 @default.
• W4315566139 hasAuthorship W4315566139A5031340334 @default.
• W4315566139 hasAuthorship W4315566139A5058658304 @default.
• W4315566139 hasAuthorship W4315566139A5072093447 @default.
• W4315566139 hasAuthorship W4315566139A5074615917 @default.
• W4315566139 hasAuthorship W4315566139A5083092931 @default.
• W4315566139 hasAuthorship W4315566139A5086604902 @default.
• W4315566139 hasAuthorship W4315566139A5087840806 @default.

• next